title: Lipoprotein(a) in subjects with familial defective apolipoprotein B100.
abstract: The plasma lipoprotein(a) (Lp(a)) concentration and apolipoprotein(a) (apo(a)) phenotype were determined in the members of two families affected with familial defective apo B100 (FDB), resulting from the Arg3500----Gln mutation in apo B that disrupts binding to LDL receptors. Eleven different phenotypic species of apo A were identified, five of which were present in both families. Although there was a general increase in Lp(a) concentration as the size of the predominant apo(a) component decreased, there was considerable variability and in three clear instances the concentration of an inherited phenotypic species was atypically low. In five cases where a direct comparison could be made, the plasma Lp(a) concentration was significantly higher in heterozygous FDB subjects than in their non-FDB siblings or close relatives with the same phenotype. However, in vitro competition studies using purified Lp(a) that had been reduced with dithiothreitol to remove the apo(a) component, indicated that the Lp(a) from FDB heterozygotes contained a smaller proportion of defective particles than their LDL. Lp(a) particles containing normal and binding-defective apo B were present at approximately the same concentration, suggesting that the increase in Lp(a) concentration observed in FDB subjects could not be explained by the inability of the particles containing the defective apo B100 to be cleared through LDL-receptor mediated processes.
authors.affiliation: MRC Lipoprotein Team, Hammersmith Hospital, London, U.K.
authors.forename: Y F
authors.initials: YF
authors.lastname: Perombelon
authors.forename: J J
authors.initials: JJ
authors.lastname: Gallagher
authors.forename: N B
authors.initials: NB
authors.lastname: Myant
authors.forename: A K
authors.initials: AK
authors.lastname: Soutar
authors.forename: B L
authors.initials: BL
authors.lastname: Knight
mesh_terms: D053299:Apolipoprotein B-100; D001054:Apolipoproteins A / Q000235:genetics / Q000378:metabolism; D001055:Apolipoproteins B / Q000235:genetics*; D005260:Female; D006579:Heterozygote; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood / Q000235:genetics*; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000097:blood* / Q000235:genetics; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D009154:Mutation; D010375:Pedigree; D010641:Phenotype; D011973:Receptors, LDL / Q000378:metabolism
chemical_list: D053299:Apolipoprotein B-100; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D017270:Lipoprotein(a); D008074:Lipoproteins; D008077:Lipoproteins, LDL; D011973:Receptors, LDL